-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Previous estimates of breast cancer overdiagnosis may have been overestimated, a modeling study based on data from the Breast Cancer Screening Consortium, the most authoritative breast cancer screening dataset in the United States, found
The United States Preventive Services Task Force (USPSTF) has identified overdiagnosis as one of the major potential harms associated with mammography because of the burden and adverse outcomes of unnecessary treatment
Researchers at Duke University and the Fred Hutchinson Cancer Research Center studied data from the Breast Cancer Surveillance Consortium facility to estimate the rate of overdiagnosed breast cancer in contemporary mammography, a cohort of 35,986 women, 82,677 mammograms and 718 breast cancer diagnoses
The findings may help women who are considering mammograms better understand the risks of overdiagnosis, an editorial from Massachusetts General Hospital said
year